Many experts said the drug was not only expensive but it was still under trial in most countries and its efficacy was yet to be ... Jun 23
Consolidated Net Profit rises by 64% to Rs. 1,908.39 Mn. in Q3 FY 2019-20. Consolidated EBITDA rises by 1.2% to Rs. ... Feb 15